Skip to content

Artificial Shrinkage of Fresh Blastocysts

Artificial Shrinkage of Fresh Blastocyst: Impact on Success Rates in Assisted Reproductive Technology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02988544
Acronym
BlastoCollapse
Enrollment
150
Registered
2016-12-09
Start date
2018-05-20
Completion date
2022-02-22
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Assisted Reproductive Technology

Keywords

Single blastocyst embryo transfer, Artificial Shrinkage, Clinical pregnancy rate, Cell free

Brief summary

The aim of the study is to determine if collapsing an embryo (or making it fold compactly by taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in assisted reproductive technology (ART). Women coming to our ART center will be randomized in two groups : the collapsing group and a control group. Pregnancy rates will be compared in the two groups. A biomarker (cell free DNA) will also be determined in each group and correlated to pregnancy occurrence.

Detailed description

This is a prospective randomized study designed to determine if artificial shrinkage (AS) before transfer of embryos impact clinical pregnancy rate in single blastocyst embryo transfer (SBET) cycle. Women elected for SBET will be randomized on transfer day in two arms:the AS group where blastocoelic cavity is artificially reduced by a laser pulse prior to transfer and a control group. Clinical pregnancy rates will be compared. Secondarily, rate of monozygotic twin pregnancy and cell free DNA concentration in culture medium will be evaluated in the two groups.

Interventions

Artificial shrinkage of blastocyst

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Couple eligible for a transfer of a single embryo at the blastocyst stage * Available couple for a follow up of 12 months

Exclusion criteria

* Attempt with frozen embryo or frozen oocyte * Attempt with a pre-implantation diagnosis * Patient has not signed informed consent * Couple in a period of exclusion determined by a previous study * Couple under legal protection, guardianship or guardianship

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy rate embryo transfer5 weeksClinical pregnancy rate by transfer evaluate by the visualization of at least one gestational sac with fetal heart activity during pelvic ultrasound confirmed by a positive result of the quantitative βHCG blood test.

Secondary

MeasureTime frameDescription
Twin pregnancy rate by transfer5 weeksTwin pregnancy rate by transfer evaluate the presence of 2 cardiac activities on ultrasound.
Free DNA levelBaselineFree DNA content contained in the drop of culture medium collected after transfer.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026